Heart Attack News and Research

RSS
Radiation therapy could improve cardiac function in heart failure

Radiation therapy could improve cardiac function in heart failure

PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

PROFID EHRA trial aims to personalize the prevention of sudden cardiac death after myocardial infarction

Academic medical centers may help mitigate structural racism in cardiovascular care for Black women

Academic medical centers may help mitigate structural racism in cardiovascular care for Black women

Nerve-immune system cross-talk: Key to zebrafish heart regeneration

Nerve-immune system cross-talk: Key to zebrafish heart regeneration

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Intensive blood pressure treatment lowers risk of cardiovascular events in high-risk patients

Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest

Current vitamin D dosing recommendations not high enough for optimal heart health, studies suggest

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Recaticimab injection every 1-3 months may safely lower bad cholesterol

Study shows long-term cardiovascular benefits of tight blood pressure control after pregnancy

Study shows long-term cardiovascular benefits of tight blood pressure control after pregnancy

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

Researchers encourage flexible approach to blood transfusion decisions for heart attack patients with anemia

Single injection of new medication effectively eliminates Lp(a) for nearly one year

Single injection of new medication effectively eliminates Lp(a) for nearly one year

CRISPR-based gene-editing therapy could offer hope for people with inherited high LDL cholesterol

CRISPR-based gene-editing therapy could offer hope for people with inherited high LDL cholesterol

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

SELECT trial: Semaglutide reduces cardiovascular events by 20% in overweight or obese patients without diabetes

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Liberal blood transfusion may reduce recurrence risk, improve survival in heart attack patients with anemia

Heart attack patients without traditional risk factors have high levels of coronary calcium, study finds

Heart attack patients without traditional risk factors have high levels of coronary calcium, study finds

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

New calculator estimates a person’s cardiovascular disease risk over the next 30 years

Study finds even small changes in movement patterns can improve heart health

Study finds even small changes in movement patterns can improve heart health

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

Positive antiphospholipid antibodies linked to increased cardiovascular risk in lupus patients

BMI should not be used to determine eligibility for gender-affirming chest surgery

BMI should not be used to determine eligibility for gender-affirming chest surgery

Yabing Chen receives NIH grants to advance vascular disease research

Yabing Chen receives NIH grants to advance vascular disease research

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.